Kobayashi Yutaka

Avg. Two Year Performance

109% Avg. Purchase Return

45% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	3%	2%	13%	22%	109%
Purchase Success Rate	3 of 4	3 of 4	3 of 4	3 of 4	4 of 4
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

MediciNova Inc.

Drugs » Biotechnology

Director:

Holdings: 106.8K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--